143 related articles for article (PubMed ID: 11376647)
1. Post-marketing surveillance of Norplant((R)) contraceptive implants: II. Non-reproductive health(1).
International Collaborative Post-Marketing Surveillance of Norplant.
Contraception; 2001 Apr; 63(4):187-209. PubMed ID: 11376647
[TBL] [Abstract][Full Text] [Related]
2. Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
International Collaborative Post-Marketing Surveillance of Norplant
Contraception; 2001 Apr; 63(4):167-86. PubMed ID: 11376646
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization.
Meirik O; Farley TM; Sivin I
Obstet Gynecol; 2001 Apr; 97(4):539-47. PubMed ID: 11275025
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
6. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Norplant implants among Thai women in Bangkok.
Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
[TBL] [Abstract][Full Text] [Related]
8. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
9. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
11. Use of Norplant implants in a New York City clinic population.
Gerber S; Westhoff C; Lopez M; Gordon L
Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
[TBL] [Abstract][Full Text] [Related]
12. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
13. Norplant implants and cardiovascular disease.
Petitti DB; Siscovick DS; Sidney S; Schwartz SM; Quesenberry CP; Psaty BM; Raghunathan TE; Koepsell TD; Longstreth WT
Contraception; 1998 May; 57(5):361-2. PubMed ID: 9673845
[TBL] [Abstract][Full Text] [Related]
14. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Datey S; Gaur LN; Saxena BN
Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptoms and Norplant contraceptive implants.
Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy after removal of Norplant implants contraceptive.
Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
[TBL] [Abstract][Full Text] [Related]
17. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
[TBL] [Abstract][Full Text] [Related]
18. Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
Contraception; 1993 Aug; 48(2):120-32. PubMed ID: 8403909
[TBL] [Abstract][Full Text] [Related]
19. A five-year evaluation of NORPLANT II implants in China.
Gu S; Du M; Zhang L; Liu Y; Wang S; Sivin I
Contraception; 1994 Jul; 50(1):27-34. PubMed ID: 7924320
[TBL] [Abstract][Full Text] [Related]
20. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
Arowojolu AO; Ladipo OA
Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
